Company intelligence / Profile preview

PolyPeptide Group

Ownership: Private
Development stage: Commercial

Overview

As a leading CDMO in the field of peptides and oligonucleotides, PolyPeptide has manufactured over one thousand GMP-grade peptides since its founding. It supports pharmaceutical and biotech companies globally with development and manufacturing services spanning early R&D to full commercial supply. The company’s products are used in approved drugs as well as investigational therapies across multiple therapeutic areas. It does not develop proprietary clinical candidates but enables the pipelines of its clients.

Notably, it manufactures around half of all currently approved peptide drug substances worldwide.

Therapeutic areas: CardiovascularMetabolic DisordersDermatologyOncologyRare DiseasesNeurology
Modalities: PeptidesOligonucleotidesRecombinant proteinSmall molecule
Industry: Contract Manufacturing Organization

Partnerships

Manufactures APIs for numerous global pharma/biotech companies including support for Alzinova AB’s ALZ‑101 program among others. Specific partnership details are typically confidential due to CDMO business model.

Beyond the preview

Go deeper on PolyPeptide Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PolyPeptide Group.

Explore the full profile